Jeffrey D Borrebach
Overview
Explore the profile of Jeffrey D Borrebach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mady L, Baddour K, Hodges J, Magana L, Schwarzbach H, Borrebach J, et al.
Oral Oncol
. 2022 May;
129:105882.
PMID: 35513955
No abstract available.
2.
Mady L, Baddour K, Hodges J, Magana L, Schwarzbach H, Borrebach J, et al.
Oral Oncol
. 2022 Feb;
126:105766.
PMID: 35168191
Objective: Compare survival of head and neck cancer (HNC) patients treated with surgical or non-surgical management according to frailty, quantify frailty with the Risk Analysis Index (RAI), a validated 14-item...
3.
Altieri Dunn S, Bellon J, Bilderback A, Borrebach J, Hodges J, Wisniewski M, et al.
PLoS One
. 2021 Feb;
16(2):e0246669.
PMID: 33556123
Background: Processes for transferring patients to higher acuity facilities lack a standardized approach to prognostication, increasing the risk for low value care that imposes significant burdens on patients and their...
4.
Beane J, Borrebach J, Billderback A, Onuma A, Adam M, Zureikat A, et al.
Am J Surg
. 2020 Dec;
222(1):29-34.
PMID: 33317810
Background: The aim of this analysis is to compare the postoperative outcomes of resection and enucleation of small pancreatic neuroendocrine tumors (PNETs). Methods: The 2014-17 American College of Surgeons-NSQIP dataset...
5.
Saadeddin Z, Borrebach J, Hodges J, Avgerinos E, Singh M, Siracuse J, et al.
J Vasc Surg
. 2020 Sep;
72(4):1427-1435.e1.
PMID: 32972588
Objective: This study aimed to develop risk predictive models of 30-day mortality, morbidity, and major adverse limb events (MALE) after bypass surgery for aortoiliac occlusive disease (AIOD) and to compare...
6.
Al Abbas A, Borrebach J, Pitt H, Bellon J, Hogg M, Zeh 3rd H, et al.
J Gastrointest Surg
. 2020 Jul;
25(6):1503-1511.
PMID: 32671801
Background: Pancreatoduodenectomy (PD) is often performed in frail patients and is associated with significant morbidity. The five-factor modified frailty index (mFI-5) has been utilized to predict adverse postoperative outcomes, but...
7.
Shah R, Borrebach J, Hodges J, Varley P, Wisniewski M, Shinall Jr M, et al.
J Am Geriatr Soc
. 2020 Apr;
68(8):1818-1824.
PMID: 32310317
Background: Frailty is a marker of dependency, disability, hospitalization, and mortality in community-dwelling older adults. However, existing tools for measuring frailty are too cumbersome for rapid point-of-care assessment. The Risk...
8.
Varley P, Borrebach J, Arya S, Massarweh N, Bilderback A, Wisniewski M, et al.
Ann Surg
. 2020 Mar;
274(6):e1230-e1237.
PMID: 32118596
Objective: The goal of this project was to first address barriers to implementation of the Risk Analysis Index (RAI) within a large, multi-hospital, integrated healthcare delivery system, and to subsequently...
9.
Beane J, Borrebach J, Zureikat A, Kilbane E, Thompson V, Pitt H
Ann Surg
. 2019 Oct;
274(4):e355-e363.
PMID: 31663969
Objective: Our aims were to assess North American trends in the management of patients undergoing pancreatoduodenectomy (PD) and distal pancreatectomy (DP), and to quantify the delivery of optimal pancreatic surgery....
10.
Al Abbas A, Borrebach J, Bellon J, Zureikat A
J Gastrointest Surg
. 2019 Aug;
24(10):2259-2268.
PMID: 31468333
Background: Higher MELD scores correlate with adverse operative outcomes regardless of the presence of liver disease, but their impact on pancreatectomy outcomes remains undefined. We aimed to compare 30-day adverse...